Hallmark Financial Services, Inc. (HALL) Analysts See $0.23 EPS; 10 Analysts Bullish Abeona Therapeutics Inc. (ABEO)

February 14, 2018 - By Pete Kolinski

Among 10 analysts covering Abeona Therapeutics (NASDAQ:ABEO), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Abeona Therapeutics had 36 analyst reports since December 16, 2015 according to SRatingsIntel. The stock of Abeona Therapeutics Inc. (NASDAQ:ABEO) earned “Buy” rating by H.C. Wainwright on Monday, October 16. H.C. Wainwright maintained it with “Buy” rating and $30.0 target in Thursday, January 4 report. Cantor Fitzgerald maintained the shares of ABEO in report on Monday, September 25 with “Buy” rating. H.C. Wainwright maintained the stock with “Buy” rating in Monday, September 18 report. Maxim Group maintained the stock with “Buy” rating in Tuesday, July 18 report. The company was maintained on Monday, October 9 by H.C. Wainwright. The rating was maintained by Jefferies on Friday, September 22 with “Buy”. Cantor Fitzgerald maintained it with “Overweight” rating and $34 target in Thursday, October 12 report. The firm has “Buy” rating by Jefferies given on Tuesday, November 21. Maxim Group initiated it with “Buy” rating and $6.0 target in Wednesday, December 16 report. See Abeona Therapeutics Inc. (NASDAQ:ABEO) latest ratings:

08/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $30.0 Maintain
07/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $34.0 Maintain
01/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $30.0 Maintain
29/01/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $34.0 Maintain
23/01/2018 Broker: RBC Capital Markets Rating: Buy New Target: $26.0 Maintain
04/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $30.0 Maintain
22/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $30.0 Maintain
21/11/2017 Broker: Jefferies Rating: Buy New Target: $28.0 Maintain
08/11/2017 Broker: SunTrust Rating: Buy New Target: $26 Initiates Coverage On
02/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $23.0 Maintain

Analysts expect Hallmark Financial Services, Inc. (NASDAQ:HALL) to report $0.23 EPS on March, 8.They anticipate $0.43 EPS change or 215.00% from last quarter’s $-0.2 EPS. HALL’s profit would be $4.18 million giving it 10.77 P/E if the $0.23 EPS is correct. After having $-0.09 EPS previously, Hallmark Financial Services, Inc.’s analysts see -355.56% EPS growth. The stock increased 0.10% or $0.01 during the last trading session, reaching $9.91. About 2,514 shares traded. Hallmark Financial Services, Inc. (NASDAQ:HALL) has risen 0.69% since February 14, 2017 and is uptrending. It has underperformed by 16.01% the S&P500.

The stock decreased 3.78% or $0.45 during the last trading session, reaching $11.45. About 1.04 million shares traded or 9.77% up from the average. Abeona Therapeutics Inc. (NASDAQ:ABEO) has risen 151.02% since February 14, 2017 and is uptrending. It has outperformed by 134.32% the S&P500.

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering gene therapy and plasma products for severe and life-threatening rare diseases. The company has market cap of $535.58 million. The companyÂ’s lead programs are ABO-101, an adeno-associated virus based gene therapies for Sanfilippo syndrome type B; and ABO-102, which are AAV based gene therapies for Sanfilippo syndrome type A. It currently has negative earnings. It is also developing EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); EB-201 for for epidermolysis bullosa (EB); ABO-201 gene therapy for juvenile Batten disease; ABO-202 gene therapy for treatment of infantile Batten disease; ABO-301, an AAV gene therapy for Fanconi anemia disorder; and ABO-302 using a novel CRISPR/Cas9 gene editing approach to gene therapy program for rare blood diseases.

Hallmark Financial Services, Inc., through its subsidiaries, underwrites, markets, distributes, and services property/casualty insurance products to businesses and individuals in the United States. The company has market cap of $179.95 million. The firm operates in the Standard Commercial, Specialty Commercial, and Personal divisions. It currently has negative earnings. The Standard Commercial segment offers standard commercial lines of insurance products primarily in the non-urban areas of Texas, New Mexico, Idaho, Oregon, Montana, Washington, Utah, Wyoming, Arkansas, Hawaii, and Missouri.

Investors sentiment decreased to 0.82 in 2017 Q3. Its down 0.43, from 1.25 in 2017Q2. It worsened, as 5 investors sold Hallmark Financial Services, Inc. shares while 23 reduced holdings. 7 funds opened positions while 16 raised stakes. 11.10 million shares or 0.91% more from 11.00 million shares in 2017Q2 were reported. Roumell Asset Mngmt holds 4.84% of its portfolio in Hallmark Financial Services, Inc. (NASDAQ:HALL) for 177,327 shares. Ny State Common Retirement Fund owns 12,900 shares. Tower Research Ltd Liability Corp (Trc) owns 1,994 shares for 0% of their portfolio. Bessemer Grp Incorporated holds 0% of its portfolio in Hallmark Financial Services, Inc. (NASDAQ:HALL) for 15,300 shares. Legal General Group Inc Pcl stated it has 0% in Hallmark Financial Services, Inc. (NASDAQ:HALL). Moreover, Wells Fargo & Mn has 0% invested in Hallmark Financial Services, Inc. (NASDAQ:HALL). Rhumbline Advisers, a Massachusetts-based fund reported 18,865 shares. Wedge Capital Mngmt L Ltd Partnership Nc, North Carolina-based fund reported 23,900 shares. Manufacturers Life Ins Commerce The has invested 0% of its portfolio in Hallmark Financial Services, Inc. (NASDAQ:HALL). Centaur Capital Ptnrs Ltd Partnership has invested 0.76% of its portfolio in Hallmark Financial Services, Inc. (NASDAQ:HALL). Jacobs Levy Equity Mgmt Inc, a New Jersey-based fund reported 15,866 shares. 245,600 are owned by Renaissance Techs Limited Company. Cove Street Cap Limited holds 2.35% in Hallmark Financial Services, Inc. (NASDAQ:HALL) or 1.82M shares. First Quadrant Ltd Partnership Ca holds 2,065 shares or 0% of its portfolio. Boston Ptnrs reported 0.01% of its portfolio in Hallmark Financial Services, Inc. (NASDAQ:HALL).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>